Similar articles

• B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.

  Indraccolo S, Mion M, Zamarchi R, Veronesi A, Veronese ML, Panozzo M, Betterle C, Barelli A, Borri A, Amadori A, et al. Indraccolo S, et al. J Clin Immunol. 1993 Nov;13(6):381-8. doi: 10.1007/BF00920013. J Clin Immunol. 1993. PMID: 7507125
• Protective immunity against HIV infection: lessons from HIV-2 infection.

  Rowland-Jones S. Rowland-Jones S. Future Microbiol. 2006 Dec;1(4):427-33. doi: 10.2217/17460913.1.4.427. Future Microbiol. 2006. PMID: 17661633 Review.
• B-cell activation and HIV-1 infection: deeds and misdeeds.

  Amadori A, Chieco-Bianchi L. Amadori A, et al. Immunol Today. 1990 Oct;11(10):374-9. doi: 10.1016/0167-5699(90)90144-x. Immunol Today. 1990. PMID: 2103733 Review. No abstract available.
• B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

  Cagigi A, Nilsson A, De Milito A, Chiodi F. Cagigi A, et al. Vaccine. 2008 Jun 6;26(24):3016-25. doi: 10.1016/j.vaccine.2007.11.063. Epub 2007 Dec 17. Vaccine. 2008. PMID: 18164520 Review.
• Clonal patterns in the human immune response to HIV-1 infection.

  Müller S, Nara P, D'Amelio R, Biselli R, Gold D, Wang H, Köhler H, Silverman GJ. Müller S, et al. Int Rev Immunol. 1992;9(1):1-13. doi: 10.3109/08830189209061779. Int Rev Immunol. 1992. PMID: 1484266 Review. No abstract available.